What is it about?
Chymotrypsin-Trypsin are proteolytic enzymes, indicated for reducing soft tissue edema and inflammation as they hasten the healing of damaged tissues and thereby, promotes a complication free recovery. So , we did used this proteolytic enzyme in combination with Diclofenac Potassium to compare the adjuvant effect on the postoperative sequelae management , when compared to Diclofenac Potassium alone.
Photo by National Cancer Institute on Unsplash
Why is it important?
The adjuvant action of Chymotrypsin-trypsin on Diclofenac Potassium was found to be clinically and statistically superior than the use of Diclofenac Potassium alone for management of post-operative sequelae after extraction of impacted mandibular third molars. The research assessed the parameters such as pain, swelling, trimus and interincisal opening after the third molar surgery amongst both the groups and reported a significantly better results with clinically evident reduction in swelling, trismus and interincisal opening with the use of Chymotrypsin-Trypsin.
Read the Original
This page is a summary of: Trypsin‐chymotrypsin as an adjuvant to diclofenac potassium on the postoperative sequelae following mandibular third molar impactions—A comparative study, Oral Surgery, April 2022, Wiley, DOI: 10.1111/ors.12742.
You can read the full text:
The following have contributed to this page